Respigen Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 05-07-2024
- Paid Up Capital ₹ 0.20 M
as on 05-07-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 05-07-2024
- Revenue 103.15%
(FY 2020)
- Profit 15042.70%
(FY 2020)
- Ebitda 647.26%
(FY 2020)
- Net Worth 9.38%
(FY 2020)
- Total Assets 6.12%
(FY 2020)
About Respigen Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹3.50 M.
Mohan Venkobarao and Bangalore Muralimohan serve as directors at the Company.
- CIN/LLPIN
U85110KA2010PTC053358
- Company No.
053358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Respigen Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Venkobarao  | Director | 23-Apr-2010 | Current |
| Bangalore Muralimohan | Director | 23-Apr-2010 | Current |
Financial Performance of Respigen Healthcare.
Respigen Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 103.15% increase. The company also saw a substantial improvement in profitability, with a 15042.7% increase in profit. The company's net worth moved up by a moderate rise of 9.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Respigen Healthcare?
In 2019, Respigen Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samleen Bio Engineering Private LimitedActive 42 years 11 monthsMohan Venkobarao is a mutual person
- Pearl Plaza Investments And Leasing Private LimitedActive 32 years 11 months
Mohan Venkobarao is a mutual person
- Institute For Dental Lab Services Private LimitedActive 27 years 7 months
Mohan Venkobarao is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 11 Nov 2011 | ₹3.50 M | Open |
How Many Employees Work at Respigen Healthcare?
Unlock and access historical data on people associated with Respigen Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Respigen Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Respigen Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
